Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2019; 16(5):704-710. doi:10.7150/ijms.32089 This issue Cite

Review

Human Trabecular Meshwork Progenitors

Qin Zhu1, Yuan Zhang2, Sean Tighe2, Yongsong Liu3, Yingting Zhu2✉, Min Hu1✉

1. Department of Ophthalmology, Fourth Affiliated Hospital of Kunming Medical University (the Second People's Hospital of Yunnan Province); Yunnan Eye Institute; Key Laboratory of Yunnan Province for the Prevention and Treatment of ophthalmology (2017DG008); Provincial Innovation Team for Cataract and Ocular Fundus Disease, The Second People's Hospital of Yunnan Province (2017HC010); Expert Workstation of Yao Ke (2017IC064), Kunming 650021, China
2. Tissue Tech, Inc., Ocular Surface Center, and Ocular Surface Research & Education Foundation, Miami, FL, 33173 USA
3. Department of Ophthalmology, Yan' An Hospital of Kunming City, Kunming, 650051, China

✉ Corresponding authors: Min Hu, M.D., Ph.D. Department of Ophthalmology, Fourth Affiliated Hospital of Kunming Medical University, Second People's Hospital of Yunnan Province, Kunming 650021, China; Telephone: 0118615087162600; Fax: 011860871-6515665 More

Citation:
Zhu Q, Zhang Y, Tighe S, Liu Y, Zhu Y, Hu M. Human Trabecular Meshwork Progenitors. Int J Med Sci 2019; 16(5):704-710. doi:10.7150/ijms.32089. https://www.medsci.org/v16p0704.htm
Other styles

File import instruction

Abstract

Trabecular meshwork (TM) cells are a group of progenitors that have the ability to become adipocytes, chondrocytes and endothelial cells. Therefore, those adult corneal progenitors may be used as an effective therapy for trabecular meshwork diseases such as glaucoma, corneal endothelial dysfunctions such as blindness due to corneal endothelial dysfunction, and similar diseases. In order to promote the understanding of human trabecular meshwork progenitors, this article reviews human trabecular meshwork progenitor therapy and discusses its potential applications for curing human eye blindness.

Keywords: trabecular meshwork, progenitor, cell-based therapy, glaucoma

Citation styles

APA
Zhu, Q., Zhang, Y., Tighe, S., Liu, Y., Zhu, Y., Hu, M. (2019). Human Trabecular Meshwork Progenitors. International Journal of Medical Sciences, 16(5), 704-710. https://doi.org/10.7150/ijms.32089.

ACS
Zhu, Q.; Zhang, Y.; Tighe, S.; Liu, Y.; Zhu, Y.; Hu, M. Human Trabecular Meshwork Progenitors. Int. J. Med. Sci. 2019, 16 (5), 704-710. DOI: 10.7150/ijms.32089.

NLM
Zhu Q, Zhang Y, Tighe S, Liu Y, Zhu Y, Hu M. Human Trabecular Meshwork Progenitors. Int J Med Sci 2019; 16(5):704-710. doi:10.7150/ijms.32089. https://www.medsci.org/v16p0704.htm

CSE
Zhu Q, Zhang Y, Tighe S, Liu Y, Zhu Y, Hu M. 2019. Human Trabecular Meshwork Progenitors. Int J Med Sci. 16(5):704-710.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use